Related Experiment Videos
Gastric effects of PAF
1Departamento de Farmacología y Farmacotecnia, Universidad de Valencia, Spain.
Methods and Findings in Experimental and Clinical Pharmacology
|January 1, 1989
Summary
Platelet-activating factor (PAF) is a potent ulcerogen implicated in gastric mucosal diseases. While its role in septic shock-induced gastric damage is clear, further research is needed for other conditions.
Area of Science:
- Gastroenterology
- Pathophysiology
- Pharmacology
Background:
- Platelet-activating factor (PAF) is recognized as a potent ulcerogen.
- PAF is hypothesized to contribute to the pathogenesis of various gastric mucosal diseases.
Purpose of the Study:
- To review the gastric actions of PAF.
- To analyze the mechanisms underlying PAF's gastric effects.
- To evaluate PAF's role in gastric mucosal damage.
Main Methods:
- Literature review of studies on PAF's gastric effects.
- Analysis of proposed mechanisms of PAF-induced gastric damage.
- Evaluation of evidence for PAF's involvement in different gastric conditions.
Main Results:
- PAF is a significant factor in gastric ulcerogenesis.
- The role of PAF in gastric damage during septic shock is well-established.
- Mechanisms of PAF's gastric actions are analyzed.
Conclusions:
- Clinical application of PAF antagonists is recommended for septic shock-related gastric damage.
- The involvement of PAF in other forms of gastric mucosal injury requires further investigation.